We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.38B
| $7.39M | 0.04% |
56,847
+333
| +0.6% | +$43.9K |
|
|
PXD
377
DELISTED
Pioneer Natural Resource Co.
PXD
| $7.32M | 0.04% |
43,975
+15,144
| +53% | +$2.29M |
|
378
BP
BP
$109B
| $7.29M | 0.04% |
266,740
+47,973
| +22% | +$1.2M |
|
379
Vodafone
VOD
$37B
| $7.28M | 0.04% |
471,284
-53,221
| -10% | -$881K |
|
380
Morgan Stanley
MS
$336B
| $7.25M | 0.04% |
74,554
+36,996
| +99% | +$3.67M |
|
381
Exelon
EXC
$46.7B
| $7.24M | 0.04% |
209,868
+24,965
| +14% | +$853K |
|
382
Cboe Global Markets
CBOE
$30.2B
| $7.18M | 0.04% |
58,007
+997
| +2% | +$122K |
|
383
General Mills
GIS
$19.3B
| $7.17M | 0.04% |
119,844
+35,216
| +42% | +$2.08M |
|
384
Cintas
CTAS
$80.9B
| $7.07M | 0.04% |
74,280
-3,428
| -4% | -$335K |
|
385
Timken Company
TKR
$8.92B
| $6.98M | 0.04% |
106,679
+104,225
| +4,247% | +$7.75M |
|
386
Ameriprise Financial
AMP
$49.5B
| $6.95M | 0.04% |
26,304
+15,254
| +138% | +$3.99M |
|
387
Sherwin-Williams
SHW
$88.2B
| $6.94M | 0.04% |
24,825
+10,193
| +70% | +$2.98M |
|
388
Vanguard Materials ETF
VAW
$3.08B
| $6.94M | 0.04% |
40,080
+60
| +0.1% | +$10.9K |
|
389
Goldman Sachs Equal Weight US Large Cap Equity ETF
GSEW
$1.94B
| $6.92M | 0.04% |
103,590
+29,445
| +40% | +$2.02M |
|
390
Revvity
RVTY
$12.7B
| $6.91M | 0.04% |
39,872
-33
| -0.1% | -$5.82K |
|
|
DLY
391
DoubleLine Yield Opportunities Fund
DLY
$683M
| $6.87M | 0.04% |
359,371
+352,196
| +4,909% | +$6.95M |
|
392
Packaging Corp of America
PKG
$22.5B
| $6.86M | 0.04% |
49,912
+13,342
| +36% | +$1.9M |
|
393
First Trust Cloud Computing ETF
SKYY
$3.01B
| $6.85M | 0.04% |
65,043
-1,846
| -3% | -$198K |
|
394
Freeport-McMoran
FCX
$95.5B
| $6.84M | 0.04% |
210,385
+62,515
| +42% | +$2.2M |
|
395
Nuveen California Quality Municipal Income Fund
NAC
$1.84B
| $6.84M | 0.04% |
436,200
| – | – |
|
396
Ericsson
ERIC
$33.3B
| $6.78M | 0.04% |
605,502
+113,865
| +23% | +$1.35M |
|
397
Roper Technologies
ROP
$39.3B
| $6.78M | 0.04% |
15,192
+1,250
| +9% | +$599K |
|
398
ARK Innovation ETF
ARKK
$6.01B
| $6.77M | 0.04% |
61,249
+9,222
| +18% | +$1.11M |
|
399
Entegris
ENTG
$21.8B
| $6.75M | 0.04% |
53,667
+6
| +0% | +$723 |
|
400
Genuine Parts
GPC
$18.3B
| $6.75M | 0.04% |
55,678
-24,944
| -31% | -$3.11M |
|
Similar funds
NAMI
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.